Skip to main content

Table 3 Proportion of patients with serum creatinine elevation > 1.5 times that at baseline

From: Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin

Day % Patients with serum creatinine elevation > 1.5 P-Value
Electrolyte Supplementation Arm % (n) Non-electrolyte Arm % (n)
Day 7 6.1 (48) 30.2 (43) 0.0025
Day 14 8.9 (45) 36.6 (41) 0.002
Day 21 2.3 (43) 43.9 (41) < 0.0001
Day 28 0 (27) 24 (25) 0.0068